BACKGROUND Typically occurring on the external genitalia, anogenital warts (AGWs) are
benign epithelial skin lesions caused by human papillomavirus infection. AGWs are usually …

… A few previous economic analyses of genital wart therapy … An economic evaluation should
preferably reflect real clinical … evaluation of this preparation in adults with genital warts …

… to genital warts. These estimates have been used in a previously published economic
evaluation of HPV … have also been used in economic evaluations of HPV vaccination are broadly …

… No treatment hierarchy for external anogenital warts (AGW) is currently recommended, …
a treatment hierarchy based on a health economic analysis of local treatments for AGW from …

… for penile warts and the 0.15% cream formulation is easy to apply for patients with vulvar and
anal warts. A very … Randomised controlled trial and economic evaluation of patient applied …

… In search of estimates of per-patient costs, we also investigated the economic evaluations
of various health technologies for prevention or treatment of EGW. Amongst the plethora of …

… about the value of vaccination against genital warts,1 … of care for use in further economic
evaluations of HPV vaccination. … Future economic evaluations of HPV vaccination will be able to …

… In Italy the prevalence of genital warts in women (15–64 years) is … evaluate the
diagnostic-therapeutic pathway, duration and setting of treatment, costs of episodes of condyloma …

… Anogenital warts (AGWs) are benign epithelial skin lesions that are predominantly caused
… (HPV types 6 and 11), but are sometimes associated with other types of oncogenic HPV [1]. …

… The potential savings to the health service from GW prevention by the quadrivalent vaccine
were considered in the economic evaluation of vaccine choice in 2007 in the UK.8 At that …